Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
5.69
+0.06 (1.07%)
Aug 22, 2025, 4:00 PM - Market closed
Immatics Market Cap
Immatics has a market cap or net worth of $691.67 million as of August 22, 2025. Its market cap has decreased by -39.27% in one year.
Market Cap
691.67M
Enterprise Value
150.19M
1-Year Change
-39.27%
Ranking
Category
Stock Price
$5.69
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $691.67M, an increase of 300.97%. That is a compound annual growth rate of 23.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 691.67M | -18.49% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | 678.78M | 263.23% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |